[Clinical evaluation of clindamycin-2-palmitate for ophthalmic infections of children].
D000038:Abscess / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002981:Clindamycin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D003231:Conjunctivitis / Q000188:drug therapy; D003320:Corneal Ulcer / Q000188:drug therapy; D003607:Dacryocystitis / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005128:Eye Diseases / Q000188:drug therapy*; D005141:Eyelid Diseases / Q000188:drug therapy; D005260:Female; D006726:Hordeolum / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007239:Infections / Q000188:drug therapy*; D008297:Male; D010169:Palmitic Acids; D013210:Staphylococcus / Q000187:drug effects; D014606:Uveitis, Anterior / Q000188:drug therapy
D010169:Palmitic Acids; D002981:Clindamycin